Reuters logo
BRIEF-Alliqua Biomedical sells TheraBond 3D Antimicrobial Barrier Systems product line
2017年9月5日 / 中午12点03分 / 2 个月内

BRIEF-Alliqua Biomedical sells TheraBond 3D Antimicrobial Barrier Systems product line

Sept 5 (Reuters) - Alliqua Biomedical Inc

* Alliqua Biomedical Inc announces the sale of TheraBond 3D Antimicrobial Barrier Systems product line; Alliqua updates fiscal year outlook

* Sees FY 2017 revenue up about 13 to 19 percent

* Sees FY 2017 revenue $18.4 million to $19.3 million

* Alliqua Biomedical Inc - for fiscal year 2017 company still expects cash burn from operations to be approximately $12.0 million

* Alliqua Biomedical says Alliqua sold all assets associated with its TheraBond 3D Antimicrobial Barrier Systems product line to Argentum Medical, LLC

* Alliqua Biomedical Inc - Alliqua will use proceeds from sale for working capital purposes and to reduce its outstanding debt balance

* Alliqua Biomedical Inc - as a result of the transaction, company’s lender has agreed to defer all principal payments until January 31, 2018

* Alliqua Biomedical Inc - aggregate purchase price for TheraBond product line was approximately $3.8 million

* Alliqua Biomedical - net of payments to Alliqua’s senior secured lender of $1.65 million, Alliqua received proceeds of approximately $1.65 million at closing Source text for Eikon: Further company coverage:

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below